Michelle has worked in the IT Industry for over 10 years as a successful business owner and entrepreneur.  The company she founded, E Com Industries, as the predominant provider of gift cards and owners of www.giftvouchers.com, serviced over 100 major Australian retail brands including Coles Myer and Woolworths expanding operations into the UK, South Africa and New Zealand.  In December 2005, E Com was acquired for $30m cash, returning over 4.6 times investment to shareholders and achieving an IRR of over 30% despite the tech sector crash in 2000.

Post acquisition, Michelle was retained for 12 months to oversee further global expansion of the technology and to undertake new business development activities (off-shore and on-shore) for the acquirer, Retail Decisions PLC.

For three years prior to establishing E Com, Michelle was the Managing Director of Sydney-based computer and web design firm, Networks Beyond 2000.  In addition to her obvious business acumen, Michelle has over 10 years experience in research and development with leading Australian Universities and the Commonwealth Scientific and Industrial Research Organization (CSIRO) where she not only worked in technical areas but also in corporate public affairs.   

Michelle holds a Bachelor of Science (Hons First Class) Degree (University of Sydney) and, as a recipient of both Commonwealth and CSIRO Postgraduate Research Awards completed a Master of Science Degree (University of Sydney) and was awarded her PhD in Applied Science (University of Canberra).  Michelle was the Vice-Chancellor’s nominee and subsequently selected as a Queens Trust representative, has lectured in the Faculty of Applied Science, guest lectured MBA marketing students, was a representative on Academic Board, Faculty Board and the Student Welfare Committee. She also established the Canberra University Postgraduate Association and Canberra Tertiary Tutoring College. 

Michelle currently resides on the Boards of two non-profit organisations: McDonald College, Australia’s leading performing arts school, and Round It Up Australia, a retail based charity.  She is also a member of the Australian Venture Capital Association (AVCAL) and the Entrepreneurs Organisation (EO).

 

Paul has over recent years assisted and led early-stage and mid stage companies achieve business results in order to attract funding and transform their ideas, technologies and products into sustainable successful businesses.

Paul joined the OneVentures team in June 2008 following the merger of Andover Venture Partners and OneVentures.  Paul was most recently CEO of Medcenter Holdings Inc. a Latin America based on-line pharmaceutical marketing company, a position he held until December 2007.  Previously he served as President and CEO of Orchid Cellmark (Nasdaq:ORCH), the worlds leading provider of genetic testing services, from June 2003.  During his tenure at both companies he developed and implemented major operational and strategic restructurings.  From 1995 to 2001, Dr. Kelly served as CEO of Gemini Genomics (Nasdaq:GMNI), a clinical genomics company which he co-founded in 1995 to discover and commercialize novel gene-based targets.  At Gemini, Dr. Kelly positioned the company for one of the UK’s largest ever biotechnology IPOs, completed strategic corporate acquisitions in Sweden and Canada, and negotiated collaborations with some of the worlds leading research institutions. In 2001, Dr. Kelly oversaw the company’s successful merger with Sequenom (Nasdaq:SQNM), valuing Gemini at over $250M, after which he served for a short period as Executive Vice President.

Before becoming a biotechnology executive, Dr. Kelly had a distinguished career as a researcher and physician specializing in endocrinology at St Vincent’s Hospital, Sydney, Australia.  While serving as a Research Physician at the Garvan Institute for Medical Research in Sydney, Paul authored over 100 scientific publications, largely in genetic epidemiology of common metabolic disorders.

Paul has co-founded a number of other companies in the health sciences and technology arena, including MEARS Technologies, Inc. and AgaMatrix, Inc (a consumer medical device company), all based in the greater Boston area.  Both companies form the basis of Andover Group’s Venture Fund I.

Paul has served on national governmental advisory bodies, as well as on the boards of public and private companies. He served on the Board of Directors of the American Society of Medicine, Law and Ethics from 2005 to 2008.  Dr. Kelly is a graduate of the University of New South Wales where he received his Bachelor of Medicine, Bachelor of Surgery (Honours), and Doctor of Medicine degrees. He is a Fellow of the Australasian College of Physicians and is a Member of the Australian Institute of Company Directors.